Ballentine Partners, LLC Bruker Corp Transaction History
Ballentine Partners, LLC
- $5.81 Billion
- Q3 2024
A detailed history of Ballentine Partners, LLC transactions in Bruker Corp stock. As of the latest transaction made, Ballentine Partners, LLC holds 4,311 shares of BRKR stock, worth $246,028. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,311
Previous 4,314
0.07%
Holding current value
$246,028
Previous $275,000
8.0%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding BRKR
# of Institutions
384Shares Held
101MCall Options Held
33KPut Options Held
39.5K-
T. Rowe Price Investment Management, Inc. Baltimore, MD13MShares$744 Million0.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.7MShares$611 Million0.01% of portfolio
-
Black Rock Inc. New York, NY9.83MShares$561 Million0.01% of portfolio
-
Pallas Capital Advisors LLC Braintree, MA9.48MShares$541 Million27.58% of portfolio
-
Massachusetts Financial Services CO Boston, MA5.46MShares$312 Million0.12% of portfolio
About BRUKER CORP
- Ticker BRKR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 148,138,000
- Market Cap $8.45B
- Description
- Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, ...